American Association for Cancer Research
Browse

sorry, we can't preview this file

crc-21-0148-s04.xlsx (20.41 kB)

Table S3 from Type-I Interferon Signaling Is Essential for Robust Metronomic Chemo-Immunogenic Tumor Regression in Murine Breast Cancer

Download (20.41 kB)
dataset
posted on 2023-04-04, 01:23 authored by Cameron Vergato, Kshama A. Doshi, Darren Roblyer, David J. Waxman

Table S3. RNAseq library sequencing stats.

Funding

U.S. Department of Defense (DOD)

History

ARTICLE ABSTRACT

Many patients with breast cancer have few therapeutic options. We show that cyclophosphamide treatment induces extensive tumor regression in a syngeneic mouse model of breast cancer via a chemo-immunogenic mechanism linked to type-I IFN production. Our findings establish that IFN signaling is essential for the robust antitumor actions of cyclophosphamide and suggest that treatment resistance may stem from silencing the IFN pathway. This suggests a new avenue for improving breast cancer treatment efficacy.

Usage metrics

    Cancer Research Communications

    Categories

    Keywords

    Breast CancerDrug MechanismsCellular responses to anticancer drugsChemotherapyImmunotherapyPreclinical Models

    Licence

    CC BY

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC